British Journal of Clinical Pharmacology · 1982 · 20 citations · 27 references
MedicinePharmacologyPharmacotherapyClinical PharmacologyEndocrine PharmacotherapyPharmacodynamicsDiabetes ControlDiabetes ManagementDiabetes MellitusDiabetes PharmacotherapyGlucose HomeostasisGlycemic ControlAntidiabetic Drug InteractionsAntidiabetic Drug TherapyBlood Glucose RegulationImpaired Glucose ToleranceOral Glucose Administration
1 The effect of acebutolol, a relatively selective beta-adrenoceptor blocking drug and propranolol, a non-selective one, on the hypoglycaemic action of glibenclamide after an oral glucose load has been investigated in a group of maturity-onset diabetic patients. 2 Glibenclamide significantly reduced the blood glucose levels and both acebutolol and propranolol, at therapeutic doses, were found to modify this action significantly. 3 The effect of acebutolol was slightly less than that of propranolol. The difference was not statistically significant. 4 The modes of action of sulphonylureas are reviewed and it is suggested that beta-adrenoceptor blockers may modify their effect on insulin release. This appears to be a drug interaction rather than an effect of beta-adrenoceptor blockade on glucose tolerance.
27
Peter Decalmer, Subhankar Chatterjee, J. M. Cruickshank et al. · Heart · 1978 · 139 citations · Full text
Beta-adrenoceptor-blocking drugs and blood sugar control in diabetes mellitus.
Alexander D. Wright, S G Barber, M J Kendall et al. · BMJ · 1979 · 137 citations · Full text